Cumberland Pharmaceuticals Inc. (CPIX)

NASDAQ: CPIX · Real-Time Price · USD

5.60

-0.07 (-1.23%)

At close: Jun 12, 2026, 4:00 PM EDT

5.89

+0.29 (5.22%)

After-hours: Jun 12, 2026, 7:59 PM EDT

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	84	60	33	25	32	69
Market Cap Growth	11.43%	80.02%	30.82%	-21.80%	-53.05%	55.71%
Enterprise Value	82.97	57.93	35.37	25.04	33.23	57.66
Last Close Price	5.60	3.98	2.37	1.79	2.25	4.67
Forward PE	-	24.00	24.00	24.00	24.00	24.00
PEG Ratio	-	1.52	1.52	1.52	1.52	1.52
PS Ratio	2.00	1.34	0.87	0.64	0.77	1.91
PB Ratio	3.88	2.39	1.45	0.85	0.89	1.61
P/FCF Ratio	61.21	12.31	-	4.35	3.87	11.04
P/OCF Ratio	59.05	12.07	-	4.15	3.82	10.86
EV/Sales Ratio	1.98	1.30	0.93	0.63	0.79	1.60
EV/EBITDA Ratio	-	42.81	-	-	-	-
EV/FCF Ratio	60.53	11.98	-	4.31	3.98	9.24
Debt / Equity Ratio	0.45	0.40	0.67	0.62	0.58	0.35
Debt / EBITDA Ratio	-	7.52	-	-	-	-
Debt / FCF Ratio	7.35	2.11	-	3.17	2.51	2.57
Net Debt / Equity Ratio	-0.04	-0.05	0.11	0.00	0.03	-0.26
Net Debt / EBITDA Ratio	0.33	-0.93	-1.70	-0.02	-3.19	3.58
Net Debt / FCF Ratio	-0.68	-0.26	-3.84	0.02	0.14	-1.76
Asset Turnover	0.57	0.58	0.48	0.45	0.47	0.40
Inventory Turnover	1.23	1.30	1.53	0.84	1.00	0.92
Quick Ratio	0.73	0.77	0.94	1.00	1.15	1.76
Current Ratio	0.95	1.01	1.15	1.28	1.60	2.37
Return on Equity (ROE)	-31.59%	-12.11%	-24.88%	-19.41%	-14.38%	-12.51%
Return on Assets (ROA)	-9.81%	-3.72%	-8.15%	-11.02%	-6.51%	-8.54%
Return on Invested Capital (ROIC)	-12.71%	-4.93%	-10.97%	-15.42%	-10.20%	-14.42%
Return on Capital Employed (ROCE)	-18.84%	-6.64%	-13.16%	-16.18%	-8.81%	-11.29%
FCF Yield	1.63%	8.12%	-	22.99%	25.84%	9.06%
Buyback Yield / Dilution	-4.12%	-5.65%	1.67%	1.82%	2.29%	1.70%
Total Shareholder Return	-4.12%	-5.65%	1.67%	1.82%	2.29%	1.70%

SEC Filings: 10-K · 10-Q